A Phase III, Multisite, Double-blinded Randomized Trial of BNT327 in Combination With Chemotherapy (Etoposide/Carboplatin) Compared to Atezolizumab in Combination With Chemotherapy (Etoposide/Carboplatin) in Participants With First-line Extensive-stage Small-cell Lung Cancer
Latest Information Update: 18 Nov 2026
At a glance
- Drugs Pumitamig (Primary) ; Atezolizumab; Carboplatin; Etoposide
- Indications Small cell lung cancer
- Focus Registrational; Therapeutic Use
- Acronyms ROSETTA Lung-01
- Sponsors BioNTech
Most Recent Events
- 14 Oct 2026 Planned End Date changed from 1 Mar 2029 to 1 Jul 2029.
- 14 Oct 2026 Planned primary completion date changed from 1 Dec 2028 to 1 Apr 2029.
- 02 Mar 2026 Planned number of patients changed from 621 to 661.